Inventor · disambiguated record
Tamar R. Grossman
Also filed as: GROSSMAN TAMAR R
6 granted patents·9 pending applications·14 citations·filing 2014–2024
77Inventor score
Files withIONIS PHARMACEUTICALS INC15
Top patents by PatentIndex Score
15 records- 0193US11713462B2Modulation of GYS1 expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Aug 1, 2023·2 cites·17 claims
- 0292US10280423B2Compositions and methods for modulating complement factor B expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted May 7, 2019·10 cites·36 claims
- 0387US2024247268A1Modulators of Complement Factor BIONIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0485US2023357776A1Compositions and methods for modulating complement factor b expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0584US11236339B2Modulation of GYS1 expressionIONIS PHARMACEUTICALS INC·Filed 2017·Granted Feb 1, 2022·2 cites·17 claims
- 0678US11926830B2Modulators of Complement Factor BIONIS PHARMACEUTICALS INC·Filed 2021·Granted Mar 12, 2024·0 cites·25 claims
- 0778US11732265B2Compositions and methods for modulating complement factor B expressionIONIS PHARMACEUTICALS INC·Filed 2021·Granted Aug 22, 2023·0 cites·28 claims
- 0877US2024141355A1Modulation of gys1 expressionIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0972US2020149047A1Modulators of complement factor bIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1065US2025051781A1Compounds and methods for modulating glycogen synthase 1IONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1165US2020048638A1Compositions and methods for modulating complement factor b expressionIONIS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1263US2016222389A1Modulators of complement factor bIONIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1362US2025346907A1Compounds and methods for reducing glycogen synthase 1IONIS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1461US2019048351A1Modulators of complement factor bIONIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1556US11197884B2Modulation of the notch signaling pathway for treatment of respiratory disordersIONIS PHARMACEUTICALS INC·Filed 2018·Granted Dec 14, 2021·0 cites·25 claims
Join the waitlist — get patent alerts
Get an alert when Tamar R. Grossman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →